DataDeposit_Impact on efficacy of target reduction of two FDA-approved ASO drugs by cellular glucose levels in in vitro cell models

Published: 5 February 2025| Version 1 | DOI: 10.17632/srn5hc25bt.1
Contributor:
Le Tra Giang Nguyen

Description

This dataset are raw and processed data for the investigation of the impact of glucose level on efficacy of two FDA approved ASO drugs. Data was classified into experiment designs.

Files

Institutions

University of Connecticut

Categories

Glucose, ELISA Sandwich, Quantitative Reverse Transcription Polymerase Chain Reaction, MTT Assay

Licence